WisdomTree ETFs Declare Distributions
Dec 23, 2016 13:30 pm UTC| Business
NEW YORK, Dec. 23, 2016 -- WisdomTree (NASDAQ:WETF) today announced that WisdomTree declared distributions for the following WisdomTree ETFs. Rates are listed below: TickerFund NameEx-dateRecord DatePay DateOrdinary...
West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call
Dec 23, 2016 13:30 pm UTC| Business
WEST DES MOINES, Iowa, Dec. 23, 2016 -- West Bancorporation, Inc. (Nasdaq:WTBA) (the “Company”), parent company of West Bank, will report its results for the fourth quarter of 2016, on Thursday, January 26, 2017 before...
Bonanza Creek Energy Announces Agreement on Comprehensive Deleveraging and Recapitalization
Dec 23, 2016 13:25 pm UTC| Business
BONANZA CREEK ENTERS INTO RESTRUCTURING SUPPORT AGREEMENT WITH BONDHOLDERS HOLDING MORE THAN $400MILLIONIN UNSECURED DEBTBONANZA CREEK’S DEBT TO BE REDUCED BY MORE THAN $850 MILLION CERTAINBONDHOLDERSCOMMIT TO PROVIDENEW...
Sighthound Unveils Sighthound Video 4.0
Dec 23, 2016 13:15 pm UTC| Business
Artificial intelligence surveillance software for the home now with audio, better human detection and higher quality video PALO ALTO, Calif., Dec. 23, 2016 -- Sighthound, Inc. today announced the release of Sighthound...
Dec 23, 2016 13:09 pm UTC| Business
Acquisition Expands Descartes’ Content Solutions with Comprehensive Logistics Trade Data WATERLOO, Ontario, Dec. 23, 2016 -- Descartes Systems Group (TSX:DSG) (Nasdaq:DSGX), the global leader in uniting...
Strongbridge Biopharma plc Provides Corporate and Financial Update
Dec 23, 2016 13:03 pm UTC| Business
~ Expands Rare Disease Portfolio through Acquisition of U.S. Rights to KEVEYIS®, the First and Only FDA-Approved Treatment for Hyperkalemic, Hypokalemic, and Related Variants of Primary Periodic Paralysis ~ ~ Provides...
Strongbridge Biopharma plc Announces Acquisition of U.S. Rights to KEVEYIS® From Taro
Dec 23, 2016 13:01 pm UTC| Business
~ KEVEYIS is the First and Only FDA-Approved Treatment for Hyperkalemic, Hypokalemic, and Related Variants of Primary Periodic Paralysis, an Ultra-Orphan, Genetic Neuromuscular Disease ~ ~ KEVEYIS is Strongbridge’s First...